Research examining psychiatric medicines and suicide outcomes can be clinically important, but it is also easy to overinterpret. People prescribed different medicines often differ in diagnosis, illness severity, previous crises, comorbidities and access to care, all of which can influence suicide risk.
An observational association between a medicine and lower suicide rates does not by itself prove that the medicine caused the reduction. The reverse problem also applies: higher event rates among people receiving a treatment may reflect the fact that clinicians prescribe it to patients who were already at greater risk.
The practical message is therefore not that one class of psychiatric medicine universally “prevents suicide”. Treatment decisions need to consider diagnosis, evidence for the individual medicine, adverse effects, monitoring and the wider care plan.
People taking antidepressants, antipsychotics, mood stabilisers or other psychiatric medicines should not stop or change treatment because of a headline about suicide risk. Concerns should be discussed with the prescribing clinician. Anyone experiencing suicidal thoughts or an immediate mental-health crisis should seek urgent professional help.
